Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Dec 30, 2015
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2015-12-28$2.85/sh−10,155$28,942→ 429,975 total
Footnotes (2)
- [F1]The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.
- [F2]Represents the weighted average sales price for shares sold in multiple transactions. Sales prices ranged from $2.80 to $2.95 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.